Related Experiment Video
Updated: Jun 6, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
[Guidelines for the treatment of functional constipation]
A Bautista Casasnovas1, F Argüelles Martín, L Peña Quintana
1Servicio de Cirugía Pediátrica, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain. adolfo.bautista@usc.es
Insights
Childhood constipation affects 5-30% of children. Oral polyethylene glycol 3350 (PEG) is the preferred disimpaction treatment, alongside diet and behavioral changes for maintenance therapy.
Area of Science:
- Pediatrics
- Gastroenterology
Context:
- Childhood constipation is a prevalent condition, impacting 5-30% of children.
- Current treatment involves explanation, disimpaction, and maintenance therapy.
- Oral polyethylene glycol 3350 (PEG) has become the standard for disimpaction.
Purpose:
- To outline current best practices for managing childhood constipation.
- To emphasize the shift towards oral disimpaction methods.
- To highlight the importance of individualized care and patient communication.
Summary:
- Recommended treatment includes explanation, disimpaction, and maintenance therapy (diet, behavior, laxatives).
- Oral polyethylene glycol 3350 (PEG) is the preferred disimpaction agent.
- Maintenance therapy aims for daily, painless defecation to prevent recurrence.
Impact:
- Oral PEG is safe, effective, and well-tolerated for children of all ages.
- Early intervention with oral laxatives can improve functional constipation resolution.
- Advances in understanding the enteric nervous system may lead to new treatments.
Abstract:
Constipation is common in childhood. It can affect around 5-30% of the child population, depending on the criteria used for diagnosis. The currently recommended treatment is based on three main points: a) explanation, b) disimpaction and c) maintenance therapy consisting of diet changes, behavioural modification, and the use of laxatives. In the last decades treatment on disimpaction have changed radically from the rectal route to the oral route with polyethylene glycol 3350 (PEG), the most used and accepted regimen nowadays. Treatment and care should take into account the individual needs and preferences of the patient. Good communication is essential, to allow patients to reach informed decisions about their care. Maintenance therapy consists of dietary interventions, toilet training, and laxatives to obtain daily painless defaecation in order to prevent re-accumulation of stools. Maintenance therapy should be start as soon as the child's bowel is disimpacted. Early intervention with oral laxatives may improve complete resolution of functional constipation. Enemas using phosphate, mineral oil, or normal saline are effective in relieving rectal impaction, but carry the risk of mechanical trauma and are not recommended for maintenance therapy in the paediatric population. Among osmotic agents, polyethylene glycol 3350 plus electrolyte solutions appear to be the first-line drug treatment to use in children of any age, as it is safe, effective, and well-tolerated. Recommended doses ranges from 0.25 to 1.5g/kg. Advances in the understanding of the gastrointestinal enteric nervous system and epithelial function have led to the development of new substances that bind to serotonin receptors or are chloride channel activators.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...